Announces Collaboration with Mark Cuban Cost Plus Drug Company to Make Prescription Drugs More Affordable

LOS ANGELES, April 2, 2024 /PRNewswire/ — In a significant step to improve healthcare affordability, has joined forces with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), marking a notable phase of transparency and ease of access in the prescription drug market. This…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks